Germline variants of IGHV3-53 / V3-66 are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine

Detalles Bibliográficos
Autores principales: Mashimo, Yoichi, Yamazaki, Keiko, Kageyama, Takahiro, Tanaka, Shigeru, Taniguchi, Toshibumi, Matsushita, Kazuyuki, Igari, Hidetoshi, Hanaoka, Hideki, Yokote, Koutaro, Nakajima, Hiroshi, Onouchi, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627529/
https://www.ncbi.nlm.nih.gov/pubmed/36341890
http://dx.doi.org/10.1016/j.jinf.2022.10.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627529/
https://www.ncbi.nlm.nih.gov/pubmed/36341890
http://dx.doi.org/10.1016/j.jinf.2022.10.015

Ejemplares similares